Bone marrow aspirate was performed and confirmed the diagnosis of BPDCN with the following immunophenotype: CD123++/CD4+/CD56+/HLA-DR++/CD304+/CD45RA+/CD43+/CD36+. This evidence concerns the gene NCAM1 and CD4+/CD56+ hematodermic neoplasm.